Haptoglobin and Iron in Parkinson's Disease

NCT02422992 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 342

Last updated 2016-11-29

No results posted yet for this study

Summary

This is a case/control epidemiology study to identify what are the iron-metabolism abnormalities in Parkinson's disease (PD) patients, and risk factors relevant to PD predisposition.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Paola Costa-Mallen, PhD · Bastyr University

Eligibility

Min Age
35 Years
Max Age
92 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02422992 on ClinicalTrials.gov